Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:03 PM UTC
| NCT Number | NCT07195695 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT07195695 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 27 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07195695 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07195695 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.